American Oncology Network, LLC | Strategic Alliance Partners


Latest from American Oncology Network, LLC

Optimizing Therapy for Patients With RRMM

March 26, 2021

Advice for clinical pharmacists who help manage patients with relapsed/refractory multiple myeloma in the current era of novel therapies and recommendations to improve upon current practice patterns.

RRMM: Adopting Anti-BCMA Therapy into Practice

March 17, 2021

Robert Mancini, PharmD, BCOP, FHOPA, of St. Luke’s Cancer Institute: Boise, comments on his experience navigating challenges using belantamab mafodotin, an anti-BCMA therapy, to treat relapsed/refractory multiple myeloma.